SOL SpA (SOL.MI) stock: key figures, P/E, revenue and dividend
Materials · Italy · ISIN IT0001206769
SOL SpA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.61 bn EUR | 1.78 bn EUR |
| Gross profit | 1.17 bn EUR | 292.00 m EUR |
| Operating income | 237.78 m EUR | 269.17 m EUR |
| EBIT | 237.00 m EUR | 270.00 m EUR |
| Net income | 147.00 m EUR | 166.00 m EUR |
| Diluted EPS – continuing operations | 1.63 EUR | 1.84 EUR |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SOL SpA
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.
More stocks
- LANDSTAR SYSTEM INC (LSTR)
- Hundsun Technologies Inc (600570.SS)
- Weatherford International plc (WFRD)
- SENSIENT TECHNOLOGIES CORP (SXT)
- China State Construction International Holdings Ltd (3311.HK)
- Seibu Holdings Inc (9024.T)
- Genting Singapore Ltd (G13.SI)
- JinkoSolar Co. Ltd. A (688223.SS)
- Wolong Electric Group Co Ltd (600580.SS)
- WYNDHAM HOTELS & RESORTS, INC. (WH)
- Howden Joinery Group PLC (HWDN.L)
- Australian Foundation Investment Company Ltd (AFI.AX)
Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.